This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Empowering pharmacytechnicians enhances team efficiency, improves patient care, and fosters a positive work culture, driving pharmacy success in a competitive landscape.
That was the question on the minds of a lot of health care professionals, public policy leaders, public health officials, and select politicians going into the first meeting of the new Advisory Committee on Immunization Practices (ACIP) in June 2025. Editor's Footnote In May 2025, Secretary Robert F. Kennedy Jr.
NHS England (NHSE) has confirmed the funding allocated to each Additional Roles Reimbursement Scheme (ARRS) role for 2025/26, including pharmacists and pharmacytechnicians. Primary care networks (PCNs) will be able to claim 66,972 per clinical pharmacist (Band 7-8a) working under the scheme, according to the latest contract.
Related Videos Related Content Advertisement June 20th 2025 FDA Approves Dupilumb for Treatment of Bullous Pemphigoid Aislinn Antrim, Managing Editor May 28th 2025Pharmacy Focus: Navigating Seasonal Allergies Luke Halpern, Assistant Editor Derek Webb, PharmD June 20th 2025 Self-Care Measures for Preventing and Managing Dysmenorrhea Yvette C.
Accessed July 23, 2025. Accessed July 23, 2025. Pneumococcal disease—pneumococcal vaccine recommendations. Last Updated October 26, 2024. CDC—AdultVaxView. Vaccination coverage among adults in the United States, National Health Interview Survey, 2022. Last Updated October 4, 2024. Hong K, Zhou F, Tsai Y, et al.
The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, showcased significant advances across a range of malignancies, with novel agents, biomarker-driven strategies, and long-term outcomes data offering new insights into cancer treatment with implications for pharmacy practice.
Soefje, PharmD, MBA, BCOP, FCCP, FHOPA Scott Soefje, PharmD, MBA, BCOP, shares insights about the evolving role of pharmacists at the 2025 OPC meeting. Soefje, PharmD, MBA, BCOP, FCCP, FHOPA Scott Soefje, PharmD, MBA, BCOP, shares insights about the evolving role of pharmacists at the 2025 OPC meeting.
Pharmacy Times : Can you share your experience at OPC 2025 and the significance of these meetings for pharmacists? Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Subscribe Now! Carlstrom, PharmD, BCOP Joseph A.
2 In April 2025, the FDA announced its plan to phase out the animal testing requirements and require new approach methodologies (NAMs) in early research to streamline which treatments will be safe and effective in humans, reduce drug development costs and timelines, and reduce testing in animals. Accessed June 19, 2025. April 10, 2025.
What pharmacy benefit managers do, and how they contribute to drug spending. March 17, 2025. Accessed June 4, 2025. Vulnerability index approach to identify pharmacy deserts and keystone pharmacies. J Am Pharm Assoc (2003). 2022;62(6):1816-1822. doi:10.1016/j.japh.2022.07.003 2022.07.003 Martin K. JAMA Netw Open.
On January 16, 2025, the FDA approved acalabrutinib (Calquence; AstraZeneca) in combination with bendamustine and rituximab for the treatment of adult patients with previously untreated mantle cell lymphoma (MCL) who are ineligible for autologous hematopoietic stem cell transplantation (HSCT). January 16, 2025. Accessed May 14, 2025.
Fournier, BSc Key Takeaways The 2024-2025 influenza season saw unprecedented severity, with high hospitalization and outpatient visit rates due to a vaccine mismatch and dominant H1N1 and H3N2 strains. 2 From October 2024 to March 2025, the CDC reported at least 37 million influenza infections, 480,000 hospitalizations, and 21,000 deaths.
In an interview with Pharmacy Times® , Gabe Hinojosa, PharmD, BCOP, clinical pharmacy specialist oncology/hematology at UT Southwestern, discussed the evolving treatment landscape for multiple myeloma (MM) and presented data from the 2025 American Society of Clinical Oncology Annual Meeting (ASCO). Accessed June 24, 2025.
SHOW MORE Pharmacy-based clinical services demonstrate both public health impact and financial sustainability. At McKesson ideaShare 2025, pharmacy leaders spotlighted the growing role of pharmacists in expanding clinical services, including telehealth, contraception prescribing, naloxone access, and point-of-care testing (POCT).
Accessed June 4, 2025. Accessed June 4, 2025. Updated February 15, 2025. Accessed June 4, 2025. Accessed June 4, 2025. Accessed June 4, 2025. Accessed June 4, 2025. Accessed June 4, 2025. Accessed June 4, 2025. REFERENCES Rivaroxaban. MedlinePlus. Updated April 15, 2023. link] Edoxaban.
1 Organizations are taking action to improve care for everyone, but pharmacists and pharmacytechnicians may be unaware of their opportunities to advance SDOH. Wick, MBA, RPh, FASCP, is the director of the Office of Pharmacy Professional Development at the University of Connecticut in Storrs. Accessed May 5, 2025.
Accessed June 17, 2025. Updated February 2025. Accessed June 17, 2025. Related Videos Related Content Advertisement July 21st 2025 Under the Weather: Unpacking the Impact of the 2024-2025 Influenza Season Tori L. Health Sci Rep. 2025;8(4):e70747. doi:10.1002/hsr2.70747 Continuous glucose monitors. link] Miller EM.
A retrospective study presented at the American Society of Health-System Pharmacists 2025Pharmacy Futures meeting has revealed significant variability in asthma treatment regimens following initial diagnosis, with many patients not receiving care aligned with the Global Initiative for Asthma (GINA) recommendations.
As health care rapidly changes, the role of pharmacists and pharmacytechnicians will have to evolve alongside it, said Donald Klepser, PhD, MBA, professor and interim dean at the University of Nebraska Medical Center. Also,] prescriptive authority, what role pharmacytechnicians play, because [these are] crucial.
At OPC 2025, Pharmacy Times® spoke with Victoria Nacher, PharmD, BCOP, from Michigan Medicine in Ann Arbor, Michigan, about emerging data and evolutions in the treatment of hematologic malignancies. Pharmacy Times : Can you share an overview of what you discussed at OPC 2025? We talked about the plenary session for [PV].
1 The findings were presented at the Revolutionizing Atopic Dermatitis (RAD) 2025 conference held in Nashville, Tennessee. RAD 2025: Long-term data on Nemluvio® (nemolizumab) demonstrate its favorable safety profile and sustained and increased improvements in itch and skin lesions in patients with atopic dermatitis up to two years.
Accessed June 5, 2025. Accessed June 5, 2025. a pharmacy-based, sun safety feasibility study. Accessed June 5, 2025. Accessed June 5, 2025. ABCDEs of Melanoma 6 REFERENCES It’s UV Awareness Month! Take a look at how AAD promotes sun safety year-round. American Academy of Dermatology. J Am Pharm Assoc (2003).
The findings from this research will be presented at the 2025 Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025. Pharmacist interventions were accepted both by providers and patients (94%). Standardized screening and further research are needed to optimize patient safety.
Related Videos Related Content Advertisement June 11th 2025 Glecaprevir/Pibrentasvir Combination Receives FDA Approval Expanded Indication for Acute HCV Kennedy Ferruggia, Assistant Editor June 3rd 2025 S2.
In April 2025, it had 4590 collection sites across the country and collected 310 tons of medications, bringing its all-time total to 9910 tons. Pharmacy kiosks: Many pharmacies, especially national chains, offer drug take-back kiosks where unwanted, unused, and expired medications can be safely disposed of. 2020;6(7):e04551.
Rockville, MD - June 4, 2025 - The U.S. USP's end-to-end supply chain analytics will help identify risks and opportunities, accelerating technology adoption and regulatory predictability. SHOW MORE Lab will help enable broader adoption of advanced manufacturing technologies and state-of-the-art quality solutions.
Image credit: LASZLO | stock.adobe.com Gabrail et al presented data from a novel strategy involving continuous subcutaneous (SC) infusion of lenalidomide in a poster at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago, Illinois. Subscribe Now!
TOC services are one of many areas where pharmacy models can improve patient outcomes, quality metrics, and hospital revenue. Accessed May 7, 2025. 2 REFERENCES 1. Hospital Readmissions Reduction Program (HRRP). Centers for Medicare & Medicaid Services. Updated September 10, 2024. 2023;60:469580231218625.doi:10.1177/00469580231218625
Accessed March 2, 2025. Accessed March 5, 2025. Accessed March 5, 2025. Clinical and Laboratory Standards Institute; 2025. Accessed March 18, 2025. Accessed March 18, 2025. Accessed March 18, 2025. Accessed March 18, 2025. Accessed March 18, 2025. Accessed March 18, 2025.
January 13, 2025. Accessed April 28, 2025. Accessed April 28, 2025. Updated April 10, 2025. Accessed April 28, 2025. Related Videos Related Content Advertisement June 25th 2025 Is Fluoride Friend or Foe? Travel Med Infect Dis. 2023;51:102494. doi:10.1016/j.tmaid.2022.102494 2022.102494 2. Travelers’ health.
July 3, 2025. Accessed July 8, 2025. Pharmacy Times. Accessed July 8, 2025. Accessed July 8, 2025. link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Doi:10.1182/blood.2024026230 2024026230 2.
A new drug application for lorundrostat is expected to be filed with the FDA in 2025. Accessed June 26, 2025. Radner, PA: Idorsia Pharmaceuticals US, Inc; 2025 April. Pradesh, India: Georges Medicines Pty Limited, 2025 June. Jansen, PharmD Candidate , Mark A. mg/d, 1 mg/d, 2 mg/d, and placebo for 12 weeks. Eur Heart J.
1 The supplemental biologics license application was accepted by the FDA for priority review in February 2025. Released June 20, 2025. Accessed June 20, 2025. February 18, 2025. Accessed June 18, 2025. Accessed June 18, 2025. News Release. News release. News release. September 11, 2024. Subscribe Now!
2025) doi:10.1001/jamanetworkopen.2025.18261 Accessed July 16, 2025. link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Spillover From an Intervention on Antibiotic Prescribing for Family Physicians. JAMA Network.
The FDA’s Prescription Drug User Fee Act date for finerenone is in July 2025. 3 Abhishek Shah, PharmD, BCCP, senior clinical pharmacy manager at Montefiore Medical Center, described the FINEARTS-HF data as “promising” and expressed hope about seeing it incorporated into guideline-directed medical therapy. March 17, 2025.
Pharmacy Times: What are some key sessions that will be presented at the upcoming 2025 ADA Scientific Sessions? Pharmacy Times: How do you anticipate the research from ADA 2025 will influence future updates to the ADA Standards of Care? Isaacs : I am so excited for the ADA Scientific Sessions. It is just so exciting.
5,6 And pharmacists and pharmacytechnicians are perfectly suited to offer guidance and sound information on vaccination’s benefits. Pharmacists and pharmacytechnicians can effectively reduce vaccine hesitancy by addressing patient concerns with empathy and professionalism. Accessed May 29, 2025. Vaccines (Basel).
Released June 27, 2025. Accessed June 30, 2025. Last Updated May 20, 2025. Accessed June 30, 2025. Accessed June 30, 2025. link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. News Release.
Released July 21, 2025. Accessed July 22, 2025. Last Updated May 20, 2025. Accessed July 22, 2025. Pharmacy Times. Accessed July 22, 2025. News Release. A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 1 (ALKS 2680-201) (Vibrance-1). National Library of Medicine.
June 9, 2025. Accessed June 9, 2025. Updated June 3, 2025. Accessed June 9, 2025. Updated June 3, 2025. Accessed June 9, 2025. Efficacy and safety of GMRx2 compared to dual combinations for the treatment of hypertension (GMRx2_ACT).
Importantly, Novavax received FDA approval in May 2025 with restrictions: It is approved for individuals 65 years and older and patients aged 12 to 64 years with at least 1 health condition that puts them at risk for severe COVID-19. 5 This option should be available for patients for the 2025-2026 flu season.
Updated January 17, 2025. Accessed July 25, 2025. July 25, 2025. Accessed July 25, 2025. May 13, 2025. Accessed July 25, 2025. July 1, 2025. Accessed July 25, 2025. Accessed July 25, 2025. Accessed July 25, 2025. Sobi announces U.S. Thrombocytopenia (low platelet count).
Finerenone and the Future of Diabetes-Related Kidney Care Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Subscribe Now!
How Recent Executive Orders Impact the Drug Pricing Landscape Nicholas Saraceno, Editor May 30th 2025 Podcast Alice Valder Curran outlines the steps manufacturers should take to better prepare for upcoming executive actions on drug pricing and market access.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content